Editor in Chief Dr KK Aggarwal, Padma Shri Awardee Dated:01 March,2020
Coronavirus enters unknown phase, fear spikes after new US case
With virtually no continent left untouched by the virus, the race is on to trace and stop further spread of the illness and also find a cure for it. India, especially, appears to be at high risk because of its dense population, deficient healthcare mechanism and high rate of migration.
Coronavirus-like epidemics have a way of confounding medical professionals. A new, more dreadful chapter in the ongoing killer virus story may have just opened after the United States reported its first case of novel coronavirus of unknown origin.
A California woman, who has no history of travel to any outbreak-hit region, is the first sign of "community spread" in the country....read more
Corona Med Talks Around the Globe - 29th February 2020
(Reproduced from JAMA)
2.The age distribution shows that most of the cases (87%) occurred in patients aged 30-79 years, while 10% were in patients 29 years and younger and 3% at 80 years and older....read more
Understanding right speech
The Upanishads, Yogasutra of Patanjali and Gautam Buddha teachings all talk about “the right speech”. As per Gautam Buddha, it has three components:
i. It should be based on truthfulness.
ii. It should be necessary....read more
Health Sutras By Dr K K Aggarwal
Any fat, which is solid at room temperature, is saturated. Trans fats are a type of saturated fat. Saturated fats are harmful to heart health.
Healthcare News Monitor
Pharmabiz India – Shardul Nautiyal
NPPA has directed merchant importers, stockists, manufacturers of active pharmaceutical ingredients (APls) and formulations to submit data of 58 APIs by March 3, 2020 to prevent illegal hoarding and black marketing in the country. The drug pricing regulator’s directive comes in the wake of outbreak of coronavirus (COVID-19) in China which has affected availability of key APls and Key Starting Materials (KSMs) in India. A committee constituted by the Department of Pharmaceuticals (DoP) identified 58 APls imported from China for monitoring of their availability and to take preventive measures over illegal hoarding and black marketing in the country. NPPA took this decision in pursuance of the powers laid down under Para 29 of Drugs Price Control Order (DPCO)-2013, which stipulates that all importers of APls, manufacturers of formulations and APls and stockists are directed to submit the information in the prescribed Form-A for merchant importers and Form-B for indigenous manufacturers or stockists duly signed by the authorised person and to be submitted before March 3, 2020 along with soft copy in excel format at email@example.com or firstname.lastname@example.org. NPPA has also urged all state drug controllers (SDCs) to ensure compliance of this order and an indicative list of importers has also been shared for ready reference. Indian Drug Manufacturers Association (IDMA), Indian Pharmaceutical Alliance (IPA), Organisation of Pharmaceuticals Producers of India (OPPI), Bulk Drug Manufacturers Association (BDMA), Federation of Indian Chambers of Commerce and Industry (FICCI), Confederation of Indian Industry (CII) and Federation of Pharma Entrepreneurs (FOPE) has also been asked to disseminate information related to it and also ensure compliance of this order.
Pharmabiz India – Laxmi Yadav
The Central Drugs Standard Control Organization (CDSCO) has issued a notice allowing submission and processing of application for registration certificate (RC) and import license simultaneously with new drug application. The notice was issued to all the stakeholders on February 26, 2020. As per the CDSCO notice, RC and import license shall be granted subject to condition of issuance of the new drug permission under New Drugs and Clinical Trials Rules, 2019. For import of drugs, the overseas manufacturing sites and the drugs are required to be registered with CDSCO as per the requirements of Rule 24 (A) and 24 of Drugs and Cosmetics (D&C) Rules, 1945. Import of drugs is regulated under chapter III of the D&C Act, 1940 and Part IV of the D&C Rules, 1945. However, for new drug, permission is required to be obtained under the New Drugs and Clinical Trial Rules, 2019 before obtaining the RC and import license. Drug industry has been raising concern time and again seeking a system of simultaneous submission and processing of such applications to avoid undue delay. To address the issue, the national regulatory authority issued the notice stating that the applicant can submit its application for obtaining RC and import license simultaneously, while submitting the application for permission for import of any new drug in the country.
The New Indian Express- PTI
The Supreme Court said on Friday the inquiry panel set up by it can look into the plea for lodging FIR into the encounter killing of four persons accused in the gang-rape and murder of a veterinarian in Telangana last year. The family members of the gunned down accused had moved the apex court for a direction to register the FIR. A Bench headed by Chief Justice S A Bobde said the family members can approach the three-member inquiry panel headed by former apex court judge V S Sirpurkar to inquire into the circumstances leading to the encounter killing of the four accused in the gang-rape and murder of the veterinarian. The petitioners agreed with the suggestion of the bench, also comprising Justice B R Gavai and Justice Surya Kant and withdrew the petition. They were also given the liberty to raise the issue of compensation before the Telangana High Court. The commission, which also included former Bombay High Court judge Rekha Sondur Baldota and ex-CBI director D R Karthikeyan, will submit its report to the Supreme Court in six months. Four accused in the gang-rape and murder of the veterinarian were killed in encounter on December 6.
The Hans India- Yadedya Talari
The police have arrested a person who traped a lady doctor and sexually assaulted her in Visakhapatnam. The accused harassed the victim by taking her obscene pictures during the intimate moments and threatened to post them on social media if she drops the relationship with him. The incident came into light when the victim approached the police station and lodged the complaint. Going into details, a person by name Srinivas Kalyan, a native of Jonnaguddi area in Vizianagaram district is into a finance business. In this context, he met with a lady doctor from Vizag, who took finance from him for her personal needs. Taking advantage of this, Srinivas traped the woman and exploited her physically. Recently, a conflict broke out between them, and the lady doctor stayed away from him. Since then, Srinivas was continuously harassing her and threatened that he'll post her nude pics on social media if she doesn't listen to him. Over this, she immediately approached Gopalapatnam police station and lodged the complaint. Upon receiving the information, the police registered an FIR under Section 417, 376,354A, 341, 321 and 506, arrested the accused and sent him to the judicial custody.